文献速递妇科生殖医学

中重度子宫内膜异位症痛经与非经期盆腔痛最严重疼痛NRS的响应性及临床意义阈值

Responsiveness and thresholds for clinically meaningful changes in worst pain numerical rating scale for dysmenorrhea and nonmenstrual pelvic pain in women with moderate to severe endometriosis.
PubMed 文献 · Fertil Steril · 2020-10-14

基于两项III期随机对照试验(EM-I和EM-II)的二次分析,评估了中重度子宫内膜异位症相关疼痛女性中,痛经(NRS-DYS)和非经期盆腔痛(NRS-NMPP)最严重疼痛数字评定量表的效用、响应性及临床意义变化阈值。研究纳入18-49岁绝经前女性,结果显示基于第3个月整体改善印象,NRS-DYS临床意义变化阈值定义为降低4分,NRS-NMPP定义为降低2分。

要点

  • NRS-DYS临床意义变化阈值定义为降低4分。
  • NRS-NMPP临床意义变化阈值定义为降低2分。
  • 两量表在中重度子宫内膜异位症疼痛女性中显示效用和响应性。

核心结论

  • 研究证明了单独使用数字评定量表评估痛经和非经期盆腔痛最严重疼痛的效用和响应性。
  • 研究确定了中重度子宫内膜异位症相关疼痛女性中NRS-DYS和NRS-NMPP的初步临床意义变化阈值。

研究设计与样本

  • 对两项III期随机临床试验(EM-I和EM-II)数据的分析。
  • EM-I入组871名女性,EM-II入组815名女性。
  • 受试者为18-49岁绝经前女性,患有中重度子宫内膜异位症相关疼痛。
  • 参与者按3:2:2随机接受安慰剂、elagolix 150 mg每日一次或elagolix 200 mg每日两次,治疗6个月。

主要发现

  • 对于第3个月整体改善印象的患者,NRS-DYS从基线至第3个月的最小二乘均值变化为-3.6(EM-I和EM-II)。
  • 对于第3个月整体改善印象的患者,NRS-NMPP从基线至第3个月的最小二乘均值变化为-1.9(EM-I)和-2.0(EM-II)。
  • NRS-DYS的测量标准误为2.99(EM-I)和2.86(EM-II)。
  • NRS-NMPP的测量标准误为1.74(EM-I)和1.71(EM-II)。
  • NRS-DYS的基线半标准差为0.78(EM-I)和0.85(EM-II)。

关键数值与推荐

  • 基于结果,NRS-DYS的临床意义变化定义为降低4分。
  • 基于结果,NRS-NMPP的临床意义变化定义为降低2分。

临床怎么用

  • 在评估中重度子宫内膜异位症相关疼痛女性的痛经时,NRS-DYS降低4分可视为临床意义变化。
  • 在评估中重度子宫内膜异位症相关疼痛女性的非经期盆腔痛时,NRS-NMPP降低2分可视为临床意义变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the utility, responsiveness, and thresholds for clinically meaningful change of a numerical rating scale for worst pain associated with dysmenorrhea (NRS-DYS) and nonmenstrual pelvic pain (NRS-NMPP) in women with moderate to severe endometriosis-associated pain. DESIGN: Analysis of data from two phase III randomized clinical trials (EM-I [NCT01620528] and EM-II [NCT01931670]). SETTING: Not applicable. PATIENT(S): Premenopausal women ages 18-49 years with moderate to severe endometriosis-associated pain. INTERVENTION(S): Participants in both trials were randomized 3:2:2 to receive placebo, elagolix 150 mg once daily, or elagolix 200 mg twice daily for 6 months. MAIN OUTCOME MEASURE(S): NRS-DYS and NRS-NMPP. RESULT(S): EM-I enrolled 871 women and EM-II enrolled 815 women. For patients with a global impression of improvement at month 3, the least-squares mean change between baseline and month 3 was -3.6 (EM-I and EM-II) for NRS-DYS and -1.9 (EM-I) and -2.0 (EM-II) for NRS-NMPP. Standard errors of measurement were 2.99 (EM-I) and 2.86 (EM-II) for NRS-DYS and 1.74 (EM-I) and 1.71 (EM-II) for NRS-NMPP. Baseline half standard deviations were 0.78 (EM-I) and 0.85 (EM-II) for NRS-DYS and 0.92 (EM-I) and 0.96 (EM-II) for NRS-NMPP. Based on these results, clinically meaningful changes were defined as a reduction of 4 points for NRS-DYS and 2 points for NRS-NMPP. CONCLUSION(S): This study demonstrated the utility and responsiveness of separate numerical rating scales to assess worst pain for dysmenorrhea and NMPP in women with moderate to severe endometriosis-associated pain and identified initial thresholds for clinically meaningful change.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Pokrzywinski RM, Soliman AM, Snabes MC, et al. Responsiveness and thresholds for clinically meaningful changes in worst pain numerical rating scale for dysmenorrhea and nonmenstrual pelvic pain in women with moderate to severe endometriosis. Fertil Steril. 2020. PMID: 33066973. doi:10.1016/j.fertnstert.2020.07.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。